Results 231 to 240 of about 11,700 (268)
Some of the next articles are maybe not open access.
Documenta Ophthalmologica, 1983
A study was made of patients, who were receiving PUVA therapy for psoriasis, to see if lens abnormalities occurred which could be due to the PUVA treatment. In a group of 42 patients there was only one eye of one patient, in which a very slight opacity was found which might possibly have developed during the therapy.
H G Ten-Jet-Foei, C A Geldof, C C Sterk
openaire +3 more sources
A study was made of patients, who were receiving PUVA therapy for psoriasis, to see if lens abnormalities occurred which could be due to the PUVA treatment. In a group of 42 patients there was only one eye of one patient, in which a very slight opacity was found which might possibly have developed during the therapy.
H G Ten-Jet-Foei, C A Geldof, C C Sterk
openaire +3 more sources
OCULAR COMPLICATIONS OF PUVA THERAPY
Australasian Journal of Dermatology, 1993SummaryPUVA, the combination of psoralen and long wave ultraviolet radiation is widely used in the management of psoriasis, vitiligo and several other dermatological disorders. The potential for long term treatment to cause ocular damage remains to be determined and despite the large numbers of patients who have received PUVA treatment, development of ...
Jo-Ann See, Paul A. Weller
openaire +3 more sources
Carcinogenic Risk of Bath PUVA in Comparison to Oral PUVA Therapy [PDF]
Dermatology, 1999 The potential carcinogenic risk of bath PUVA therapy was compared to that of systemic (oral) PUVA. An analysis of the epidemiological data on cancer risk following bath PUVA with trimethylpsoralen does not support the conclusion that bath PUVA per se is less carcinogenic than systemic PUVA with 8-methoxypsoralen (8-MOP).
S.E. Shephard, R.G. Panizzon
openaire +2 more sources
Melanonychia associated with PUVA therapy
Journal of the American Academy of Dermatology, 2003We describe a case of melanonychia induced by PUVA. This phenomenon likely is more common than the few reports in the literature indicate.
Leslie S. Ledbetter, Sylvia Hsu
openaire +3 more sources
Woronoff's Rings With PUVA Therapy
Archives of Dermatology, 1979To the Editor.— We were interested in the report by Lowe and Bures on the occurrence of Woronoff's rings (WR) in patients with psoriasis who were undergoing psoralen and ultraviolet A (PUVA) treatment (Archives114:278-279, 1978). Penneys and his colleagues1have suggested that an inhibitor of prostaglandin (PG) synthesis diffuses outward from psoriatic
Malcolm W. Greaves, A.P. Warin
openaire +3 more sources
Journal of the American Academy of Dermatology, 2001
Lichen aureus is one of the subtypes of a rare group of diseases, pigmented purpuric dermatoses. The natural course of the disease is slow evolution and slow resolution. Treatment is generally limited. We report a case of lichen aureus that responded dramatically to photochemotherapy (PUVA).
V. Goulden, Mark Goodfield, T.C. Ling
openaire +3 more sources
Lichen aureus is one of the subtypes of a rare group of diseases, pigmented purpuric dermatoses. The natural course of the disease is slow evolution and slow resolution. Treatment is generally limited. We report a case of lichen aureus that responded dramatically to photochemotherapy (PUVA).
V. Goulden, Mark Goodfield, T.C. Ling
openaire +3 more sources
Woronoff's Rings With PUVA Therapy
Archives of Dermatology, 1978A perilesional pale ring of skin that was seen during ultraviolet (UV) treatment of psoriatics was described by Woronoff in 1926.1Recent studies into the pathogenesis of Woronoff's ring (WR) phenomenon were conducted by Penneys et al2during coaltar and UV-light treatment of psoriatics.
Frank Bures, Nicholas J. Lowe
openaire +3 more sources
Der Hautarzt, 1994
Systemic PUVA photochemotherapy is widely used for a variety of skin diseases. Administration of 8-methoxypsoralen in a dilute bathwater solution may be an effective alternative therapy with no systemic side-effects and requiring smaller amounts of UVA to induce the required phototoxic response.
Gerd Plewig +2 more
openaire +4 more sources
Systemic PUVA photochemotherapy is widely used for a variety of skin diseases. Administration of 8-methoxypsoralen in a dilute bathwater solution may be an effective alternative therapy with no systemic side-effects and requiring smaller amounts of UVA to induce the required phototoxic response.
Gerd Plewig +2 more
openaire +4 more sources
Dose Measurement in PUVA Therapy
Dermatology, 1979The dose emitted by the fluorescent tubes used in PUVA therapy is not constant: it varies in function of time, age of the lamps, and several other factors. Exact knowledge of the dose given to the patient requires continuous measurement and integration of the UV-A output.
openaire +3 more sources
PUVA THERAPY OF CHRONIC ACTINIC DERMATITIS
Australasian Journal of Dermatology, 1988SummaryA modified PUVA regime was used to treat five men with long‐standing chronic actinic dermatitis. They are all now symptom free on monthly maintenance PUVA therapy and no longer react abnormally to ultra‐violet radiation, with consequent improvement of their quality of life.
Susan Sinclair, Colin Hindson
openaire +3 more sources